Imagawa M et al. |
Modulation of platelet-activating factor synthesis by recombinant interferon-alpha in human renal cell carcinoma. |
1996 |
Urol. Int. |
pmid:8840484
|
Mehta A and Sigman M |
Identification and preparation of sperm for ART. |
2014 |
Urol. Clin. North Am. |
pmid:24286775
|
Yildirim G et al. |
Effects of platelet-activating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. |
2000 |
Undersea Hyperb Med |
pmid:11191161
|
Vavilova GL et al. |
[The role of the thrombocyte-activating factor in inhibiting Na+,K(+)-ATPase in different tissues after ischemia and reperfusion of the small intestine]. |
1996 Mar-Apr |
Ukr. Biokhim. Zh. |
pmid:9005660
|
Hansen JF and Hansen BF |
[Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology]. |
1987 |
Ugeskr. Laeg. |
pmid:3324429
|
Kabasakal C et al. |
The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. |
1998 Jul-Sep |
Turk. J. Pediatr. |
pmid:9763906
|
Harputluoglu MM et al. |
The effects of Gingko biloba extract on acetic acid-induced colitis in rats. |
2006 |
Turk J Gastroenterol |
pmid:16941250
|
GamaleÄ IA et al. |
[Post-receptor formation of active forms of oxygen in nonphagocytic cells]. |
1999 |
Tsitologiia |
pmid:10496012
|
Braquet P et al. |
Is there a case for PAF antagonists in the treatment of ischemic states? |
1989 |
Trends Pharmacol. Sci. |
pmid:2688213
|
Izzo AA et al. |
Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. |
1998 |
Trends Pharmacol. Sci. |
pmid:9803830
|
Page C and Abbott A |
PAF: new antagonists, new roles in disease and a major role in reproductive biology. |
1989 |
Trends Pharmacol. Sci. |
pmid:2672467
|
GarcÃa-Sáinz JA |
Intercellular communication within the liver has clinical implications. |
1989 |
Trends Pharmacol. Sci. |
pmid:2595791
|
O'Neill C |
A physiological role for PAF in the stimulation of mammalian embryonic development. |
1991 |
Trends Pharmacol. Sci. |
pmid:2053190
|
Zimmerman GA and McIntyre TM |
PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. |
2004 |
Trends Mol Med |
pmid:15177186
|
Marathe GK et al. |
Oxidized LDL contains inflammatory PAF-like phospholipids. |
2001 Apr-May |
Trends Cardiovasc. Med. |
pmid:11686003
|
Chávez-Cartaya RE et al. |
Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes. |
1994 |
Transplantation |
pmid:8197604
|
Foegh ML et al. |
Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. |
1986 |
Transplantation |
pmid:3523888
|
Pi F et al. |
Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. |
1994 |
Transplantation |
pmid:8291097
|
Asako H et al. |
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules. |
1992 |
Transplantation |
pmid:1384191
|
Herrero-Fresneda I et al. |
Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor. |
2000 |
Transplantation |
pmid:11190497
|
Gilli UO et al. |
Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. |
2005 |
Transplantation |
pmid:15912099
|
Freiche JC et al. |
Prolonged survival of renal transplants in nonimmunized and hyperimmunized rats receiving a platelet-activating factor antagonist. |
1990 |
Transplantation |
pmid:2368154
|
Lanese DM et al. |
Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles. |
1994 |
Transplantation |
pmid:7809931
|
dos Santos OF et al. |
Effect of platelet-activating factor antagonist on cyclosporine nephrotoxicity. Glomerular hemodynamics evaluation. |
1989 |
Transplantation |
pmid:2705209
|
Makowka L et al. |
Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. |
1990 |
Transplantation |
pmid:2402783
|
Biancone L et al. |
Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation. |
2006 |
Transplantation |
pmid:16495796
|
Gu M et al. |
Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. |
2000 |
Transplantation |
pmid:11045637
|
Saumweber DM et al. |
Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS. |
1994 |
Transplantation |
pmid:8108870
|
Biancone L et al. |
Role of platelet-activating factor in functional alterations induced by xenoreactive antibodies in porcine endothelial cells. |
2000 |
Transplantation |
pmid:11063341
|
Camussi G et al. |
Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. |
1987 |
Transplantation |
pmid:3299910
|
Yin M et al. |
The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia. |
1996 |
Transplantation |
pmid:8633367
|
Nishiyama R et al. |
Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue. |
1993 |
Transplantation |
pmid:8516812
|
Kawahara K et al. |
The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung. |
1993 |
Transplantation |
pmid:8516834
|
Takada Y et al. |
Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation. |
1995 |
Transplantation |
pmid:7839408
|
Conte JV et al. |
Long-term lung preservation with the PAF antagonist BN 52021. |
1991 |
Transplantation |
pmid:2048190
|
Watson CJ et al. |
The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival. |
1993 |
Transplantation |
pmid:8212192
|
Suzuki S et al. |
The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. |
2000 |
Transplantation |
pmid:10868624
|
Fukuoka T et al. |
Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. |
1993 |
Transplant. Proc. |
pmid:8470175
|
Coughlan AF et al. |
In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. |
1993 |
Transplant. Proc. |
pmid:7692651
|
Hammer C et al. |
Xenogeneic rejection mechanisms shown by intravital microscopy. |
1998 |
Transplant. Proc. |
pmid:9865335
|
Otte KE et al. |
Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor. |
1990 |
Transplant. Proc. |
pmid:2349668
|
Borobia FG et al. |
Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats. |
1993 |
Transplant. Proc. |
pmid:8356661
|
Toledo-Pereyra LH and Suzuki S |
Cellular and biomolecular mechanisms of liver ischemia and reperfusion injury. |
1994 |
Transplant. Proc. |
pmid:8109001
|
Da Costa M et al. |
Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170. |
1990 |
Transplant. Proc. |
pmid:2389490
|
Miyatake T et al. |
Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. |
2000 |
Transplant. Proc. |
pmid:10936319
|
|
First International Alexis Carrel Conference on Lipid Mediators in Organ Transplantation. April 8-10, 1986, Washington, DC. |
1986 |
Transplant. Proc. |
pmid:3765055
|
Minor T et al. |
Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft. |
1995 |
Transplant. Proc. |
pmid:7879086
|
Ide S et al. |
Donor administration of PAF antagonist (TCV-309) enhances lung preservation. |
1995 |
Transplant. Proc. |
pmid:7879103
|
Takada Y et al. |
Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7879169
|
Yin M et al. |
Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury. |
1995 |
Transplant. Proc. |
pmid:7879180
|